A multivariate survival analysis indicated that after adjusting clinical parameters, p63 expresssion ≥5% was an independent favorable prognostic factor in overall DLBCL and ABC-DLBCL but not in GCB-DLBCL (data not shown). This evidence concerns the gene TP63 and diffuse large B-cell lymphoma.